title: Does targeting the lipophilic milieu provide advantages for an endothelin antagonist?
authors.affiliation: Vascular Biology Center, Medical College of Georgia, Augusta, GA 30912-2500, USA. dpollock@mcg.edu
authors.forename: David M
authors.initials: DM
authors.lastname: Pollock
authors.forename: Erika I
authors.initials: EI
authors.lastname: Boesen
authors.forename: Stephen M
authors.initials: SM
authors.lastname: Black
mesh_terms: D000818:Animals; D016503:Drug Delivery Systems; D055808:Drug Discovery; D065128:Endothelin Receptor Antagonists; D019332:Endothelin-1 / Q000037:antagonists & inhibitors* / Q000378:metabolism; D006801:Humans; D011485:Protein Binding; D017466:Receptors, Endothelin / Q000378:metabolism
chemical_list: D065128:Endothelin Receptor Antagonists; D019332:Endothelin-1; D017466:Receptors, Endothelin